Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•Free Press Journal
1 month ago•Bloomberg Quint
1 month ago•Moneycontrol
Procter & Gamble Health Limited has informed the Exchange regarding 'Communication in respect of deduction of tax at source (TDS) on the amount of Dividend income from Procter & Gamble Health Limited ( the Company ) '. | Download
Procter & Gamble Health Limited has informed the Exchange regarding 'Communication in respect of deduction of tax at source (TDS) on the amount of Dividend income from Procter & Gamble Health Limited ( the Company ) '. | Download
Interim • Div/Share: ₹ 45
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant